“Front-line Treatment for Chronic Lymphocytic Leukemia in 2025: Finite Duration Versus Continuous Treatment”, Can Hematol Today, vol. 4, no. 2, pp. 12–20, Sep. 2025, doi: 10.58931/cht.2025.4272.